Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Aldea

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Infectious Diseases and Therapy|November 25, 2024
Etiological, Clinical, and Epidemiological Characteristics of Acute Viral Gastroenteritis in an Adult Population in a Tertiary Level Hospital in SpainSara Herranz-Ulldemolins, Anna Sellarès-Crous, Miriam J Álvarez-Martínez, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 28, 2021
Incidence and Impact of COVID-19 in MS: A Survey From a Barcelona MS UnitMaria Sepúlveda, Sara Llufriu, Eugenia Martínez-Hernández, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2018
Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening programAndrea Buron, Marta Román, Josep M Augé, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 13, 2022
Qualitative Subgenomic RNA to Monitor the Response to Remdesivir in Hospitalized Patients With Coronavirus Disease 2019: Impact on the Length of Hospital Stay and MortalityRodrigo Alonso-Navarro, Genoveva Cuesta, Marta Santos, et al.
Lancet (London, England)|June 28, 2021
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trialAlberto M Borobia, Antonio J Carcas, Mayte Pérez-Olmeda, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 7, 2017
Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimatesMaria Sepúlveda, Marta Aldea, Domingo Escudero, et al.
Malaria Journal|August 7, 2015
Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity ratesGloria P Gómez-Pérez, Almudena Legarda, Jose Muñoz, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 7, 2023
mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple SclerosisYolanda Blanco, Domingo Escudero, Cinta Lleixà, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Infectious Diseases and Therapy|November 25, 2024
Etiological, Clinical, and Epidemiological Characteristics of Acute Viral Gastroenteritis in an Adult Population in a Tertiary Level Hospital in SpainSara Herranz-Ulldemolins, Anna Sellarès-Crous, Miriam J Álvarez-Martínez, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 28, 2021
Incidence and Impact of COVID-19 in MS: A Survey From a Barcelona MS UnitMaria Sepúlveda, Sara Llufriu, Eugenia Martínez-Hernández, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2018
Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening programAndrea Buron, Marta Román, Josep M Augé, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 13, 2022
Qualitative Subgenomic RNA to Monitor the Response to Remdesivir in Hospitalized Patients With Coronavirus Disease 2019: Impact on the Length of Hospital Stay and MortalityRodrigo Alonso-Navarro, Genoveva Cuesta, Marta Santos, et al.
Lancet (London, England)|June 28, 2021
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trialAlberto M Borobia, Antonio J Carcas, Mayte Pérez-Olmeda, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 7, 2017
Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimatesMaria Sepúlveda, Marta Aldea, Domingo Escudero, et al.
Malaria Journal|August 7, 2015
Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity ratesGloria P Gómez-Pérez, Almudena Legarda, Jose Muñoz, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 7, 2023
mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple SclerosisYolanda Blanco, Domingo Escudero, Cinta Lleixà, et al.
Pageof 3